Additionally, we identified CD8+c-Met+ tumor-infiltrating lymphocytes (TILs) in human melanoma skin biopsies [23], suggesting that targeting the HGF/c-Met pathway could control CD8+c-Met+ T cell-mediated anti-tumor immunity. The gene discussed is MET; the disease is melanoma.